RxDoctor Payments Data

Stephanie Oexeman, DPM

Foot & Ankle Surgery · Chicago, ILNPI 1427419373

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $136,698 of the $206,478 with a category attached, or 66.2%. 25 manufacturers reported payments, led by Integra Lifesciences Corporation at 51.7% of the total. Reporting peaked in 2024 at $61,059 and has fallen 69.8% since, to $18,443 in 2025. Among foot & ankle surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$206,478in general payments, 2019–2025

Across 474 payments — averaging $435.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$107K
  • Orthofix Medical, Inc.$89K
  • Medwest Associates$3K
  • Arthrex$3K
  • Stryker$1K
  • FFF Enterprises, Inc.$1K
  • plus $3K from 19 others

What the payments were for

  • Consulting fees$136,69866%
  • Speaking & faculty fees$1,0000%
  • Travel & lodging$53,76126%
  • Food & beverage$11,4186%
  • Education$3,6002%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$206,478 in reported general payments places this provider in the 95th percentile of 555 foot & ankle surgery providers in Illinois.

See all foot & ankle surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$36,101
Medicare patients
92
Services billed
419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole14$264

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →